Clinical Trials in Phoenix

Showing 2241-2260 of 7,960 trials

MIP Versus PCNL for Kidney Stone Disease

NCT04767919

The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

Kidney Stone

University of California, San Diego75 participantsStarted Jan 2021

Phoenix, Arizona, United States • San Diego, California, United States • Cleveland, Ohio, United States +3 more locations

RECRUITINGPhase 2< 1 mile

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will enroll patients with three distinct separate tumor cohorts. The cancers types are colorectal, head and neck carcinoma, and melanoma that are progressing on CPI treatment.

MelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer

Vyriad, Inc.87 participantsStarted Apr 2020

Phoenix, Arizona, United States • Durate, California, United States • Los Angeles, California, United States +24 more locations

MIP Versus PCNL for Kidney Stone Disease

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Find Trials by Condition in Phoenix

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis

Outcomes of a Skill-Based Program for Eating Disorders

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799)

Outcome of Patients with Severe Functional TR According to Medical, Transcatheter or Surgical Treatment